Literature DB >> 9366683

A case of Erdheim-Chester disease with orbital involvement.

C Valmaggia1, J Neuweiler, C Fretz, I Gottlob.   

Abstract

The Erdheim-Chester disease is a rare idiopathic, systemic, histiocytic disorder. To our knowledge, ocular involvement has been reported in only 16 cases. We describe a 55-year-old man who had symmetrical exophthalmos and several skin nodules on the arms and trunk. A magnetic resonance imaging scan confirmed the presence of bilateral, intraconal, retrobulbar tumors. An examination of the histopathologic features of orbital and skin biopsy specimens revealed xanthogranulomatous infiltrate with Touton giant cells. Further systemic investigations showed bone and retroperitoneal involvement. Three years later, multiple eyelid xanthelasmas developed in the patient. These findings are consistent with the diagnosis of the Erdheim-Chester disease. The patient's condition is stable under therapy with low-dose corticosteroids. His survival is longer than usually described in the literature.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366683     DOI: 10.1001/archopht.1997.01100160637021

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

Review 1.  Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review.

Authors:  J A Sivak-Callcott; J Rootman; S L Rasmussen; R A Nugent; V A White; D Paridaens; Z Currie; G Rose; B Clark; A A McNab; F V Buffam; J M Neigel; M Kazim
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  Erdheim-Chester disease: a case report.

Authors:  Esther M Hoffmann; Wibke Müller-Forell; Susanne Pitz; Herbert Radner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

3.  Erdheim-Chester disease: a case report with pulmonary, kidney involvement and bone lesions.

Authors:  Aziza Mounach; Abderrzak Nouijai; Lahsen Achemlal; Abdellah El Maghraoui; Ahmed Bezza
Journal:  Rheumatol Int       Date:  2009-07-09       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.